Point72 Asset Management L.P. lifted its holdings in CME Group Inc (NASDAQ:CME) by 399.3% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 299,758 shares of the financial services provider’s stock after buying an additional 239,726 shares during the period. Point72 Asset Management L.P. owned approximately 0.09% of CME Group worth $48,483,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also made changes to their positions in CME. ARK Investment Management LLC bought a new stake in CME Group during the 4th quarter valued at $120,000. Signaturefd LLC bought a new position in shares of CME Group in the first quarter worth $138,000. Old Mutual Global Investors UK Ltd. bought a new position in shares of CME Group in the first quarter worth $138,000. AlphaOne Investment Services LLC bought a new position in shares of CME Group in the fourth quarter worth $146,000. Finally, Mosaic Family Wealth LLC bought a new position in shares of CME Group in the fourth quarter worth $146,000. Hedge funds and other institutional investors own 82.20% of the company’s stock.
In other news, Director Ronald A. Pankau sold 250 shares of the stock in a transaction dated Thursday, June 7th. The shares were sold at an average price of $171.51, for a total transaction of $42,877.50. Following the completion of the sale, the director now directly owns 3,559 shares in the company, valued at $610,404.09. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Chairman Terrence A. Duffy sold 20,000 shares of the stock in a transaction dated Tuesday, May 22nd. The stock was sold at an average price of $161.00, for a total transaction of $3,220,000.00. Following the sale, the chairman now owns 94,686 shares of the company’s stock, valued at $15,244,446. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 32,885 shares of company stock valued at $5,320,171. 0.45% of the stock is currently owned by company insiders.
CME Group opened at $170.48 on Thursday, according to Marketbeat Ratings. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.10. The stock has a market cap of $57.92 billion, a price-to-earnings ratio of 35.74, a price-to-earnings-growth ratio of 2.40 and a beta of 0.55. CME Group Inc has a 12-month low of $119.30 and a 12-month high of $174.36.
CME Group (NASDAQ:CME) last posted its earnings results on Thursday, April 26th. The financial services provider reported $1.86 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.85 by $0.01. The company had revenue of $1.10 billion during the quarter, compared to analyst estimates of $1.12 billion. CME Group had a net margin of 111.45% and a return on equity of 8.48%. CME Group’s revenue for the quarter was up 18.4% on a year-over-year basis. During the same period in the prior year, the business posted $1.22 earnings per share. sell-side analysts predict that CME Group Inc will post 6.78 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Monday, June 25th. Stockholders of record on Friday, June 8th will be issued a dividend of $0.70 per share. The ex-dividend date of this dividend is Thursday, June 7th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.64%. CME Group’s dividend payout ratio is currently 58.70%.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.